Rivotril Clonazepam

Rivotril is a well-known brand of clonazepam, a medication belonging to the benzodiazepine class. It was originally developed by the Swiss healthcare company Hoffmann-La Roche (Roche) in the mid-20th century and has since become one of the most widely recognized brands for treating seizure disorders and panic attacks globally.

Today, while Roche remains the original developer, the commercial rights and manufacturing responsibilities vary by region due to licensing agreements and the divestment of mature brands. In several European and international markets, the brand is managed by Cheplapharm Arzneimittel, a German pharmaceutical company that specializes in acquiring established legacy brands from larger pharmaceutical firms. Manufacturing occurs in multiple certified pharmaceutical facilities across Europe and other continents to ensure global supply compliance.